97 related articles for article (PubMed ID: 11155482)
1. [Immunologic and epidemiologic characterization of non-responders/low-responders to hepatitis B vaccine].
Ramos I; Oliveira J; Alves V; Côrte-Real R; Santos-Rosa M; Silvestre AM
Acta Med Port; 2000; 13(4):159-65. PubMed ID: 11155482
[TBL] [Abstract][Full Text] [Related]
2. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates.
Jafarzadeh A; Zarei S; Shokri F
Vaccine; 2008 Jan; 26(2):269-76. PubMed ID: 18037544
[TBL] [Abstract][Full Text] [Related]
3. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I
HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875
[TBL] [Abstract][Full Text] [Related]
4. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.
Jafarzadeh A; Montazerifar SJ
J Ayub Med Coll Abbottabad; 2006; 18(4):4-9. PubMed ID: 17591001
[TBL] [Abstract][Full Text] [Related]
5. Investigation of memory B cell responses to hepatitis B surface antigen in health care workers considered as non-responders to vaccination.
Valats JC; Tuaillon E; Funakoshi N; Hoa D; Brabet MC; Bolloré K; Ducos J; Vendrell JP; Blanc P
Vaccine; 2010 Sep; 28(39):6411-6. PubMed ID: 20682363
[TBL] [Abstract][Full Text] [Related]
6. Study of hepatitis B (HB) vaccine non-responsiveness among health care workers from an endemic area (Taiwan).
Yen YH; Chen CH; Wang JH; Lee CM; Changchien CS; Lu SN
Liver Int; 2005 Dec; 25(6):1162-8. PubMed ID: 16343067
[TBL] [Abstract][Full Text] [Related]
7. Effect of GM-CSF in combination with hepatitis B vaccine on revacination of healthy adult non-responders.
Lin C; Zhu J; Zheng Y; Chen Y; Wu Z; Chong Y; Gao Z
J Infect; 2010 Apr; 60(4):264-70. PubMed ID: 20138189
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of vaccination against hepatitis B in adult with HIV infection].
Kalinowska-Nowak A; Bociaga-Jasik M; Garlicki A; Mach T
Przegl Epidemiol; 2007; 61(2):339-47. PubMed ID: 17956052
[TBL] [Abstract][Full Text] [Related]
9. The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients.
Kara IH; Yilmaz ME; Suner A; Kadiroglu AK; Isikoglu B
Vaccine; 2004 Sep; 22(29-30):3963-7. PubMed ID: 15364445
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab.
Moses J; Alkhouri N; Shannon A; Raig K; Lopez R; Danziger-Isakov L; Feldstein AE; Zein NN; Wyllie R; Carter-Kent C
Am J Gastroenterol; 2012 Jan; 107(1):133-8. PubMed ID: 21876562
[TBL] [Abstract][Full Text] [Related]
11. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
[TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of a modified process hepatitis B vaccine in healthy adults ≥50 years.
Gilbert CL; Klopfer SO; Martin JC; Schödel FP; Bhuyan PK
Hum Vaccin; 2011 Dec; 7(12):1336-42. PubMed ID: 22185811
[TBL] [Abstract][Full Text] [Related]
13. Comparison of four recombinant hepatitis B vaccines applied on an accelerated schedule in healthy adults.
Hernández-Bernal F; Aguilar-Betancourt A; Aljovin V; Arias G; Valenzuela C; de Alejo KP; Hernández K; Oquendo O; Figueredo N; Figueroa N; Musacchio A; Véliz G; García E; Mollineda AD; Juvier AI; Trujillo J; Delahanty A; Ortega D; Cinza Z; González VL
Hum Vaccin; 2011 Oct; 7(10):1026-36. PubMed ID: 21941089
[TBL] [Abstract][Full Text] [Related]
14. The evaluation of the effectiveness of multiple dose intradermal hepatitis B re-vaccination in hemodialyzed patients not responding to standard method of immunization.
Radziszewski A; Gajda M; Pituch-Noworolska A; Drozdz M; Kraśniak A; Kaczmarczyk I; Hołyś S; Zurowski J; Sydor A; Sułowicz W
Przegl Lek; 2007; 64(7-8):470-5. PubMed ID: 18409347
[TBL] [Abstract][Full Text] [Related]
15. Antibody response to hepatitis B vaccine in end-stage renal disease patients.
Chow KM; Law MC; Leung CB; Szeto CC; Li PK
Nephron Clin Pract; 2006; 103(3):c89-93. PubMed ID: 16534237
[TBL] [Abstract][Full Text] [Related]
16. Immuneresponse to recombinant hepatitis B vaccination in adults.
Gandhoke I; Gupta S; Lal S; Khare S
J Commun Dis; 2003 Dec; 35(4):249-55. PubMed ID: 15909752
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers.
Wood RC; MacDonald KL; White KE; Hedberg CW; Hanson M; Osterholm MT
JAMA; 1993 Dec 22-29; 270(24):2935-9. PubMed ID: 8254853
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of immunogenicity and safety of Engerix B and Twinrix vaccine].
Gałaj A; Grześk G; Borys D; Durmowicz A; Grześk E; Szadujkis-Szadurski L
Wiad Lek; 2004; 57(5-6):217-20. PubMed ID: 15518064
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of hepatitis B vaccine among hemodialysis patients: effect of revaccination of non-responders and duration of protection.
Chaves SS; Daniels D; Cooper BW; Malo-Schlegel S; Macarthur S; Robbins KC; Kobetitsch JF; McDaniel A; D'Avella JF; Alter MJ
Vaccine; 2011 Dec; 29(52):9618-23. PubMed ID: 22044739
[TBL] [Abstract][Full Text] [Related]
20. Varying antibody response in dental health care workers vaccinated with recombinant hepatitis B vaccine.
Aspinall S; Hauman CH; Bos P; Zulch RN
J Dent Assoc S Afr; 1991 Jun; 46(6):321-4. PubMed ID: 1962318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]